Skip to main content
FinSpry Logo
FinSpry
RCUS logo
RCUS
(NYSE)
Arcus Biosciences, Inc.
$22.96-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arcus Biosciences (RCUS) Stock Price & Financial Analysis

Arcus Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.52 - $23.45
52-Week High$26.40
52-Week Low$6.50
Open$21.95
Volume1.58M
Average Volume (3M)1.58M
Market Cap2.47B
Shares Outstanding107.40M
Price to Sales (P/S)9.50
Price to Book (P/B)3.72
EV/EBITDA-7.06
Revenue (TTM)247.00M
Net Income (TTM)-353.00M
Free Cash Flow (TTM)-484.00M
EPS (TTM)$-3.29
Profit Margin-142.91%
Operating Margin-156.28%
Return on Equity (ROE)-55.94%
Debt to Equity0.16
50-Day MA$21.46
200-Day MA$16.98
52-Week Change183.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arcus Biosciences

What is the current stock price for RCUS?

As of the latest trading session, RCUS stock trades at $22.96. The 52-week range is $6.50–$26.40, with a day range of $21.52–$23.45.

What is the P/E ratio for RCUS?

The P/E ratio (Price-to-Earnings) for RCUS is shown in the Key Statistics section. This valuation metric helps compare Arcus Biosciences, Inc. to industry peers.

Does RCUS pay dividends?

Arcus Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RCUS?

Based on 7 analysts, the consensus for RCUS is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RCUS?

Arcus Biosciences's market capitalization is $2.47B, classifying it as a mid-cap company. Arcus Biosciences operates in the Healthcare sector within the Biotechnology industry.